Showing results (91-100 of 100) with videos related to
Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 100 results.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 18, 2010
Ethical considerations for participation of nondirected living donors in kidney exchange programsE S Woodle, J A Daller, M Aeder, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1997
Phase III double-blind comparison of dolasetron mesylate and ondansetron and an evaluation of the additive role of dexamethasone in the prevention of acute and delayed nausea and vomiting due to moderately emetogenic chemotherapyW S Lofters, J L Pater, B Zee, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 1997
The role of the 5-HT3 antagonists ondansetron and dolasetron in the control of delayed onset nausea and vomiting in patients receiving moderately emetogenic chemotherapyJ L Pater, W S Lofters, B Zee, et al.The American Journal of Medicine|July 1, 1989
The illusion of futility in clinical practiceJ D Lantos, P A Singer, R M Walker, et al.Nature Astronomy|January 26, 2026
Europa's ice thickness and subsurface structure characterized by the Juno microwave radiometerS M Levin, Z Zhang, S J Bolton, et al.BMC Public Health|January 12, 2020
Knowledge of heart attack and stroke symptoms among US Native American Adults: a cross-sectional population-based study analyzing a multi-year BRFSS databaseJared C Van Hooser, Krista L Rouse, Mandy L Meyer, et al.Academic Psychiatry : the Journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry|January 21, 2014
What and how psychiatry residents at ten training programs wish to learn about ethicsL W Roberts, T McCarty, C Lyketsos, et al.Annals of Surgical Oncology|March 8, 2024
Adjuvant Gemcitabine Versus Neoadjuvant/Adjuvant FOLFIRINOX in Resectable Pancreatic Cancer: The Randomized Multicenter Phase II NEPAFOX TrialThorsten O Goetze, Alexander Reichart, Ulli S Bankstahl, et al.Clinical Pharmacology and Therapeutics|December 17, 2016
Patient Perceptions of Care as Influenced by a Large Institutional Pharmacogenomic Implementation ProgramR P McKillip, B A Borden, P Galecki, et al.Clinical Pharmacology and Therapeutics|April 12, 2017
Pharmacogenomics-Based Point-of-Care Clinical Decision Support Significantly Alters Drug PrescribingP H O'Donnell, N Wadhwa, K Danahey, et al.Pageof 10